<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"alternative splicing":1,
"antigen":1,
"breast cancer":8,
"thyroid autoimmunity":1,
"thyroid peroxidase":1,
"Ectopic thyroid":1,
"Laryngeal location":1,
"Surgical treatment":1,
"leczenie chirurgiczne":1,
"lokalizacja krtaniowa":1,
"tarczyca ektopowa":1,
"Warthin-like variant":1,
"clinicopathological feature":1,
"prognosis":3,
"metastasis":4,
"mimicking":1,
"papillary":1,
"thyroid":7,
"tuberculosis":1,
"Acetate":1,
"PET-CT":1,
"Physiologic distribution":1,
"Pitfalls":1,
"biopsy":1,
"fine-needle":1,
"histology":1,
"positron emission tomography":3,
"thyroid carcinoma":9,
"thyroid nodule":3,
"carbon nanoparticles":1,
"clinically node-negative patients":1,
"lymph node dissection":1,
"papillary thyroid carcinoma":11,
"retrospective analysis":1,
"Hypothyroidism":3,
"Metastatic renal cell cancer":1,
"Sunitinib":2,
"Extrathyroid invasion":1,
"Thyroid papillary carcinoma":1,
"Ultrasonography":2,
"branchial cyst":1,
"cervical sinus":1,
"iodine deficiency":1,
"thyroid goiter":1,
"Central lymph node":1,
"Globus":1,
"Thyroidectomy":5,
"Voice":1,
"GPx":1,
"GSH":1,
"Hashimoto’s thyroiditis":3,
"LPO":1,
"Oxidative stress":1,
"catalase":1,
"thyroid cancer":23,
"thyroid goitre":1,
"Head and neck cancer":1,
"IMRT":1,
"Palliative care":1,
"RTOG 8502":1,
"Radiation":3,
"Pericardial effusion":1,
"Pleural effusion":1,
"Renal cell carcinoma":2,
"Minimally invasive video-assisted thyroidectomy (MIVAT)":1,
"benign lesion":1,
"liquid-based cytology":1,
"thyroid cytology":1,
"ACTH = adrenocorticotropic hormone":1,
"FSH = follicle-stimulating hormone":1,
"GH = growth hormone":1,
"IDH1 = isocitrate dehydrogenase 1":1,
"IDH2 = isocitrate dehydrogenase 2":1,
"LH = luteinizing hormone":1,
"MEN1 = multiple endocrine neoplasia 1":1,
"Maffucci syndrome":1,
"PCR = polymerase chain reaction":1,
"PNA = peptide nucleic acid":1,
"PRL = prolactin":1,
"RET = rearranged during transfection":1,
"SDH = succinate dehydrogenase":1,
"TSH = thyroid-stimulating hormone":1,
"isocitrate dehydrogenase":1,
"oncology":1,
"pituitary adenoma":2,
"somatic mosaicism":1,
"Fine needle aspiration cytology":2,
"Intercalated duct adenoma":1,
"Intercalated duct hyperplasia":1,
"Intercalated duct lesion":1,
"Parotid":1,
"Salivary gland":1,
"Head and neck malignancies":1,
"Simultaneous":1,
"Triple primary malignancies":1,
"18F-DOPA":1,
"Medullary thyroid carcinoma":2,
"Neuroendocrine tumours":2,
"endoscopic surgery":2,
"robotic surgery":1,
"robotic thyroidectomy":3,
"surgical outcomes":1,
"thyroid surgery":1,
"Childhood cancer survivorship":1,
"Health services":1,
"Healthcare access":1,
"Long-term follow-up care":1,
"Surveillance":2,
"Coagulación":1,
"Coagulation":1,
"Tiroides":1,
"cytopathology":1,
"differential diagnosis":1,
"poorly differentiated thyroid carcinoma":2,
"Lymph node metastasis":4,
"Papillary thyroid microcarcinoma":3,
"Prediction":1,
"Thyroid-stimulating hormone":1,
"Differentiated thyroid carcinoma":1,
"Iodine-124":1,
"PET/CT":1,
"PET/MRI":1,
"Invasion":2,
"Migration":2,
"TGFβ1":1,
"miR-663":1,
"Autoantibodies":1,
"Immunoassay":1,
"Thyroglobulin":2,
"Time-resolved":1,
"Differentiated thyroid cancer (DTC)":1,
"Meta-analysis":2,
"Recurrence":3,
"Young":1,
"99mTc-MIBI":1,
"Fine-needle aspiration cytology":1,
"Follicular neoplasms":2,
"Molecular markers":1,
"Mutation analysis":1,
"Scintigraphy":1,
"Cervical lymph node metastasis":1,
"NCDB":1,
"Papillary thyroid cancer":7,
"Prophylactic lymph node dissection":1,
"Radioactive iodine":3,
"Predictor":1,
"Glycolysis":1,
"Hexosamine biosynthetic pathway":1,
"Neoadjuvant chemotherapy":1,
"Pentose phosphate pathway":1,
"Prognostic and predictive value":1,
"Cancer-associated fibroblast":1,
"Papillary carcinoma":3,
"Anti-Tg antibody":1,
"Radioiodine ablation":2,
"Fukushima risk assessment":1,
"Japanese A-bomb survivors":1,
"Radiation epidemiology":1,
"Risk models":1,
"BRAF mutation":1,
"Body mass index":1,
"Overweight":1,
"Provox 2":1,
"Provox Vega":1,
"alaryngeal speech":1,
"device life":1,
"laryngectomy":1,
"tracheoesophageal voice prosthesis":1,
"columnar cell variant of papillary carcinoma":1,
"mucoepidermoid carcinoma":2,
"BRAFV600E mutation":1,
"Clinical outcome":1,
"Radioactive iodine therapy":2,
"TSH":1,
"Thyrotropinoma":1,
"cancer":3,
"hysterectomy":1,
"registry-based":1,
"Differentiated thyroid cancer":2,
"FDG-PET/CT":1,
"follow-up":1,
"iodine negative":1,
"radioiodine therapy":2,
"Ultrasound":2,
"cytology":1,
"fine-needle aspiration biopsy":2,
"follicular adenomas":1,
"follicular carcinomas":1,
"cataract":1,
"iodine radioisotopes":1,
"thyroid neoplasms":5,
"CD11c":1,
"CD206":1,
"hepatocellular carcinoma":1,
"polarization":1,
"tumour-associated macrophages":1,
"National Cancer Data Base":1,
"insular carcinoma":1,
"rare thyroid cancer":1,
"Lung cancer":1,
"NSCC":1,
"Pathology":2,
"TTF-1":1,
"p40":1,
"Epidemiology":2,
"and End Results (SEER)-Medicare":1,
"survival":3,
"Cervical cancer":1,
"Colorectal cancer":1,
"Gastric cancer":2,
"Jmjd1a/KDM3A":1,
"Lung adenocarcinoma":1,
"NuRD":1,
"Oct1/POU2F1":1,
"Prostate cancer":2,
"Carcinogenesis":4,
"High throughput screening":1,
"Prediction modeling":1,
"dose adjustment":1,
"hepatic impairment":1,
"lenvatinib":1,
"pharmacokinetics":2,
"pooled analysis":1,
"population":2,
"Fine needle aspiration biopsy":1,
"Inadequate material":1,
"Thyroid nodules":4,
"Biomolecular sensing":1,
"Human Thyroglobulin (TG) detection":1,
"Label-free detection":1,
"Long period fiber grating (LPG)":1,
"Optical fiber biosensor":1,
"Reflection-type LPG":1,
"GATA-3":1,
"ductal carcinoma of the breast":1,
"fine needle aspiration":1,
"immunohistochemistry":3,
"Androgen receptor (AR)":1,
"Bromodomain containing 8 (BRD8)":1,
"miR-185":1,
"Anastrozole":1,
"hormone-sensitive tissues":1,
"isoflavones":1,
"menopausal hot flushes":1,
"safety":1,
"tamoxifen":1,
"BRAF V600E":1,
"Pediatric thyroid cancer":1,
"TERT":1,
"Well differentiated thyroid carcinoma":1,
"HMGB1":1,
"Macrophage migration inhibitory factor (MIF)":1,
"TLR4":1,
"Mutations":1,
"Radiation risk":1,
"Radiobiology":1,
"Stem cells":1,
"Diagnostic markers":1,
"Epigenetic":1,
"let7":1,
"miRNAs":2,
"Adult Lhermitte–Duclos disease":1,
"Cowden syndrome (CS)":1,
"Hamartomas":1,
"Mucosal papillomatosis":1,
"Multiple neoplasms":1,
"PTEN hamartoma tumor syndrome (PHTS)":1,
"Phosphatase and tensin homolog (PTEN) gene":1,
"Thyroid adenomatous nodules":1,
"Trichilemmomas":1,
"Lymph node":2,
"Malignancy":1,
"Shear wave elastography":1,
"lateral neck dissection":1,
"robotic neck dissection":1,
"selective neck dissection":1,
"gasless unilateral axillary approach":1,
"postauricular facelift approach":1,
"hyperlipidemia":1,
"tyrosine kinase inhibitor":1,
"Anti-PD-1 therapy":1,
"PD-L1":1,
"Pembrolizumab":1,
"Phase I study":1,
"cell line":1,
"gene expression":2,
"thyroid gland":2,
"molecular biology":1,
"review":1,
"tall cell":1,
"Epithelioid hemangioendothelioma":1,
"Sarcoma":1,
"Vascular":1,
"WWTR1-CAMTA1":1,
"atypia of undetermined significance":1,
"follicular lesion of undetermined significance":1,
"thyroid FNA":1,
"Biomedicine":1,
"Cytological smear":1,
"MALDI-imaging":1,
"Mass spectrometry":1,
"Proteomics":1,
"late effects":1,
"pediatric":2,
"secondary malignancy":1,
"Benign larynx neoplasm":1,
"Larynx disease":1,
"Solitary fibrous tumour":1,
"FNAC":1,
"histopathology":3,
"primary giant cell tumor of parotid gland":1,
"Hydrocephalus":1,
"Thyroid malignancy":1,
"H19":1,
"YES1":1,
"competing endogenous RNA":1,
"long noncoding RNA":1,
"microRNA-17-5p":1,
"AKT1 mutations":1,
"Proteus syndrome":1,
"somatic mutation":1,
"Cancers":1,
"Chernobyl nuclear accident":1,
"Disaster relief planning":1,
"Psychological effects":1,
"Radiation effects":1,
"Radiation induced":1,
"BRAF inhibitors":1,
"MEK inhibitors":1,
"Radioiodine refractory thyroid cancer":1,
"Small-molecule tyrosine kinase inhibitors":1,
"autophagy":1,
"lysosomes":1,
"necrosis":1,
"obatoclax":1,
"5-FU":1,
"APE1":1,
"AT101":1,
"Her-2 positive":1,
"metformin":1,
"mouse models":1,
"obesity":1,
"thyroid carcinogenesis":1,
"Gene transcription":1,
"Nuclear receptor corepressor 1":1,
"acoustic radiation force impulse imaging":1,
"head and neck ultrasound":1,
"parathyroid adenoma":2,
"HCC":1,
"HKDC1":1,
"Proliferation":2,
"TNM staging":2,
"thyroid stimulating hormone":1,
"Levator glandulae thyroideae":1,
"Lobe of Lalouette":1,
"Pyramidal lobe":1,
"BRAF(V600E)":1,
"Sodium iodide symporter":1,
"cytotoxic chemotherapy":1,
"medullary thyroid cancer":2,
"multitargeted kinase inhibitors":1,
"personalized therapy":1,
"hyperparathyroidism-jaw tumor (HPT-JT)":1,
"malignant tumor":1,
"multiple endocrine neoplasia type 1 (MEN1)":1,
"multiple endocrine neoplasia type 2A (MEN2A)":1,
"neuroendocrine tumor":2,
"Corticosteroid":1,
"Drug-induced liver injury (DILI)":1,
"Iodine-131":1,
"SphK2":1,
"cell growth":1,
"miR-613":1,
"childhood cancer survivors":1,
"endocrine-related cancer":1,
"secondary malignant neoplasms":1,
"Central lymph node metastasis (CLNM)":1,
"Differentiated thyroid carcinoma (DTC)":1,
"Prophylactic central neck dissection (pCND)":1,
"Recurrence risk stratification (RRS)":1,
"Risk factors":2,
"Diagnosis":4,
"Risk-stratification":1,
"Staging":1,
"Therapy":3,
"ELISA":1,
"extracellular vesicle":1,
"Adenocarcinoma":1,
"Brain":1,
"Cysts":1,
"Metastases":1,
"Neurocysticercosis":1,
"bias (epidemiology)":1,
"causality":1,
"diabetes mellitus":1,
"incidence":1,
"type 2 diabetes mellitus":1,
"Gerotarget":1,
"estrogen receptor alpha":1,
"ras":1,
"senescence":1,
"transformation":1,
"SEER database":1,
"comparative effectiveness":1,
"microcarcinoma":1,
"propensity score":1,
"Surgery":1,
"Surveys and questionnaires":1,
"Glycine":1,
"Metabolism":1,
"Serine":1,
"Mucinous carcinoma":1,
"Rhabdoid cells":1,
"TSH suppression":1,
"computed tomography":1,
"differential diagnoses":1,
"mandibular metastatic carcinoma":1,
"Biopsy fine needle":1,
"cytodiagnosis":1,
"infarction":1,
"minimally invasive thyroidectomy":1,
"neuromonitoring":1,
"P54":1,
"PAK4":1,
"chemotherapy":1,
"cis-platinum":1,
"complete remission":1,
"liposomal doxorubicin":1,
"partial remission":1,
"RET":1,
"calcitonin":1,
"multiple endocrine neoplasia type 2":1,
"leiomyosarcoma":1,
"hypercalcemia":1,
"parathyroid carcinoma":1,
"parathyroid hormone":1,
"parathyroid hormone-related protein":1,
"MPHOSPH8":1,
"apoptosis":1,
"shRNA":1,
"DNA repair":1,
"SNP":1,
"cell cycle regulator":1,
"molecular genetics":1,
"let-7 family":1,
"MAPK signaling pathway":1,
"RARB":1,
"Sodium-iodide symporter":1,
"miR-106a":1,
"Guideline":1,
"dosimetry":1,
"recombinant human thyrotropin":1,
"BRAF V600E mutation":1,
"Brain tumor":1,
"Cerebral metastases":1,
"Epithelioid glioblastoma":1,
"Glioblastoma":1,
"Gliosarcoma":1,
"Rhabdoid meningioma":1,
"Tissue microarray":1,
"MicroRNA":1,
"Neoplasm Recurrence, Local":1,
"Venous Thrombosis":1,
"Malignant struma ovarii":1,
"Paraganglioma":1,
"Pheochromocytoma":1,
"Single photon emission computed tomography-computed tomography":1,
"Single photon emission computed tomography/computed tomography":1,
"carcinoma":1,
"diarrhea":1,
"vandetanib treatment":1,
"E-cadherin":1,
"β-catenin":1,
"Cerebellar hemangioblastoma":1,
"Challenging diagnosis":1,
"Metastatic cerebellar tumor":1,
"Solid tumor":1,
"Yunnan plateau":1,
"autoimmune disease status":1,
"benign thyroid disease":1,
"adrenocortical neoplasm":1,
"borderline malignant potential":1,
"oncocytoma":1,
"hypopharynx":1,
"larynx":1,
"tumor":1,
"Prevalence":1,
"Urine iodine":1,
"Multinodular goitre":1,
"Thyroid disorders":2,
"Goitre":1,
"Hypocalcaemia":1,
"Hypoparathyroidism":1,
"Multiple Endocrine Neoplasia syndrome":1,
"Whipple’s procedure":1,
"prophylactic central compartment dissection":1,
"radioiodine ablation treatment":1,
"Gardner syndrome":1,
"Turcot syndrome":1,
"familial adenomatous polyposis":1,
"Targeted therapy":1,
"CD56":1,
"HBME-1":1,
"Teratoma – diagnosis":1,
"Struma ovarii – diagnosis":1,
"Carcinoid tumor":1,
"Endoscope":1,
"Lymph Nodes":1,
"Neck Dissection":1,
"Procedures":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2016年6月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
